Why Pfizer's not worried about resistance to its new antiviral

Hello,

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let's get to it...


A headshot of Mikael Dolsten, Pfizer's chief scientific officer
Mikael Dolsten, Pfizer's chief scientific officer

Resistance is one of the biggest threats to new COVID-19 treatments. Here's why Pfizer's top scientist, Mikael Dolsten, isn't worried it will weaken the pharma giant's new pill.

Check it out>>


A customer scans her phone as she enters Amazon's new Amazon Fresh store in Ealing, west London, on March 4, 2021.
A customer scans her phone as she enters Amazon's new Amazon Fresh store in Ealing, west London, on March 4, 2021.
Amazon considers offering prescription drugs and lottery tickets in its cashierless grocery stores to boost traffic

See the exclusive now>>


little boy waiting for covid vaccine
Benjamin Hayes, age 5, at Children's National Hospital in Washington, DC.
See some of the first 5- to 11-year-old kids get their COVID-19 vaccines

Read more>>


More stories we're reading:


-Leah

Read the original article on Business Insider


from Business Insider https://ift.tt/3wp7dOS

No comments

Powered by Blogger.